HIV/AIDS Treatment

U.N. health agency reinstates two Indian AIDS drugs to approved list

Published in AIDS Weekly, December 20th, 2004

The U.N. health agency said November 30, 2004, it has reinstated two Indian-made generic drugs to its list of approved HIV/AIDS medicines for use in developing countries after the manufacturer was able to prove they were the same as the patented versions.

The drugs, lamivudine tablets and a combination of lamivudine and zidovudine, both made by Cipla Ltd., are the first of 18 Indian generic drugs that have been removed from the list this year to regain World Health Organization (WHO) approval.

"Two extremely important drugs are once again on the list and recommended for use by all our U.N. partners in developing countries," said Jim Kim, WHO's AIDS...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2004-12-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry